MiNK Therapeutics Inc
XNAS: INKT
MiNK Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The co...
Read More
12.24
0.42
(3.55%)
4,472
XNAS Volume
XNAS 21 Jan, 2026 10:40 AM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
MiNK Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..